Rilr.ai is an evidence-native formulation and therapeutics intelligence platform designed for R&D scientists, formulation engineers, and pharmaceutical research teams. It connects formulas, regulatory compliance, molecular evidence, PICO/GRADE, guidelines, trials, and expert review across formulation-intensive industries and drug R&D.

Which industries does Rilr.ai support?

Rilr.ai supports 17+ formulation-intensive industries plus pharmaceutical R&D, including food and beverage, pet nutrition, functional foods, TCM, cosmetics, cleaning, coatings, adhesives, fine chemicals, animal feed, agriculture, biotechnology, flavor and fragrance, tobacco and vape, modern beverages, wellness drinks, plant-based foods, sports nutrition, and therapeutics.

How does Rilr.ai generate formulas?

Rilr.ai uses a multi-model AI architecture with parallel processing across 8 language models including Groq Llama, DeepSeek, and Qwen. It runs three specialized modules: Module A generates the complete ingredient formula with percentages and process steps; Module B performs decision and risk assessment; Module C conducts regulatory compliance checking. Results stream progressively to users within 15-30 seconds.

Is Rilr.ai free to use?

Yes. Rilr.ai offers a free trial with 20 Credits on signup to explore the platform. The Lab Plan ($49/month) includes 50 Credits/month for individual researchers — PDF/Word export and private knowledge base included. The Team Plan ($129/month) provides 200 Credits/month for up to 5 researcher seats with shared formula library, 配方管理系统(FMS), and compliance dossier export.

How accurate are Rilr.ai formulas?

Rilr.ai formulas include a scientific integrity layer with CAS number validation, DOI hallucination detection, mandatory ingredient checks, and a quality gate requiring minimum 2,200 characters of complete formula data. Formulas include confidence scores and are grounded in industry standards (FDA 21 CFR, EU regulations, GB standards, IFRA, AAFCO, etc.).

What makes Rilr.ai different from ChatGPT for formulation?

Unlike general-purpose AI, Rilr.ai is purpose-built for formulation chemistry with: (1) Industry-specific domain knowledge for 11 formulation sectors, (2) Regulatory compliance checking against FDA, EU, GB, IFRA, and AAFCO standards, (3) Real-time streaming generation showing ingredients as they appear, (4) CAS number validation preventing hallucinated chemical data, (5) Formula export to industry-standard PDF and DOCX formats, (6) Private knowledge base integration for proprietary formulation data.

Can Rilr.ai check regulatory compliance?

Yes. Rilr.ai automatically checks regulatory compliance for each formula against applicable standards: FDA 21 CFR for US food and cosmetics, EU 1334/2008 and 1223/2009 for European markets, GB 2760 and GB/T standards for China, the current IFRA Amendment for fragrances, AAFCO 2025 for pet food, FAO/WHO specifications for agrochemicals, and more.

Does Rilr.ai support Chinese language formulation?

Yes. Rilr.ai fully supports Chinese-language formulation in both Simplified (zh-CN) and Traditional Chinese (zh-TW). The platform uses Qwen-max (Alibaba Cloud) as the primary model for Chinese regulatory knowledge, with expertise in GB standards, China National Food Safety Standards, and NMPA cosmetic regulations.

Who is Fookshing Tech (馥晟科技)?

Fookshing Tech (深圳市馥晟涵生科技有限公司) is an AI for Science company headquartered in Nanshan District, Shenzhen, Guangdong, China. Founded in 2024, it is recognized as a representative enterprise in China's formulation AI and pharmaceutical AI sectors. The company operates Rilr.ai (international), rilr.ai (global), and Peifang.ai (配方AI, China), providing AI-native decision infrastructure for formula-intensive manufacturing and drug R&D across 18+ industries.

What does Peifang.ai (配方AI) do?

Peifang.ai is the China-market platform of Fookshing Tech (馥晟科技), focused on AI-powered formula generation and pharmaceutical R&D for Chinese enterprises. "Peifang" (配方) means "formula" in Chinese. The platform integrates GB 2760 compliance, NMPA pharmaceutical standards, traditional Chinese medicine (TCM) formulation, and multi-model AI supporting Qwen and DeepSeek. It serves food manufacturers, cosmetic companies, pharmaceutical R&D teams, and chemical enterprises across China.

Is Rilr.ai used for pharmaceutical drug development?

Yes. Rilr.ai's pharmaceutical platform provides a complete Stage-Gate (S0→S6) drug development pipeline covering target discovery (S0), lead optimization with SAR/ADMET (S1), pre-clinical studies with GLP toxicology and PK/PD (S2), Phase I-III clinical trial planning (S3-S5), and NDA/BLA/CTD regulatory filing (S6). It integrates PICO/GRADE evidence retrieval, ICH guideline compliance checking, molecular structure analysis, and Hermes 24/7 regulatory monitoring (FDA/EMA/NMPA).

Rilr.ai-AI Formulation Platform for R&D Scientists